Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

A rare ovarian tumor caused hair loss in a post-menopausal woman, which almost completely stopped after surgery.

Aromatase inhibitors cause male pattern hair loss in women.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

The best way to treat androgenetic alopecia, a common type of hair loss, is through early intervention and a comprehensive approach, but some supplements may reduce the effectiveness of medical treatments.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

A woman developed male characteristics after using unregulated hormone therapy.

Iron intake has not been proven to maintain normal hair growth.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Low iron levels are linked to hair loss in women.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.